misonidazole has been researched along with Osteogenic Sarcoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ametamey, SM; Arlt, MJ; Born, W; Brennecke, P; Campanile, C; Fischer, CR; Fuchs, B; Gvozdenovic, A; Honer, M; Krämer, SD; Müller, A; Sabile, AA; Schibli, R | 1 |
| Dallaudiere, B; Hess, A; Hummel, V; Lincot, J; Maubon, A; Monteil, J; Preux, PM | 1 |
| Glatstein, E; Makuch, RW; Schwade, JG; Strong, JM | 1 |
| Brustad, T; Rofstad, EK | 1 |
| Bleehen, NM; Owen, LN; White, RA; Workman, P | 1 |
| Deys, BF; Stap, J | 1 |
| Grierson, JR; Grunbaum, Z; Koh, WJ; Krohn, KA; Rasey, JS | 1 |
1 trial(s) available for misonidazole and Osteogenic Sarcoma
| Article | Year |
|---|---|
Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Esophageal Neoplasms; Half-Life; Humans; Injections, Intravenous; Kinetics; Metabolic Clearance Rate; Misonidazole; Nitroimidazoles; Osteosarcoma; Peripheral Nervous System Diseases; Probability | 1982 |
6 other study(ies) available for misonidazole and Osteogenic Sarcoma
| Article | Year |
|---|---|
Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Fluorides; Fluorodeoxyglucose F18; Humans; Mice; Misonidazole; Osteoblasts; Osteoclasts; Osteosarcoma; Phenotype; Positron-Emission Tomography; Tibia | 2013 |
Tumoral hypoxia in osteosarcoma in rats: preliminary study of blood oxygenation level-dependent functional MRI and 18F-misonidazole PET/CT with diffusion-weighted MRI correlation.
Topics: Animals; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Femoral Neoplasms; Hypoxia; Magnetic Resonance Imaging; Male; Misonidazole; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed | 2013 |
Radiosensitizing effect of misonidazole in acute and fractionated irradiation of a human osteosarcoma xenograft.
Topics: Adolescent; Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Male; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Osteosarcoma; Transplantation, Heterologous | 1980 |
The penetration of misonidazole into spontaneous canine tumours.
Topics: Adenocarcinoma; Anesthesia, Intravenous; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Dog Diseases; Dogs; Female; Fibrosarcoma; Half-Life; Lymphoma, Non-Hodgkin; Male; Mammary Glands, Animal; Meningioma; Misonidazole; Neoplasms; Nitroimidazoles; Osteosarcoma; Pentobarbital | 1979 |
Influence of the hypoxic cell sensitizer misonidazole on the proliferation of well-oxygenated cells in vitro during prolonged exposure.
Topics: Animals; Cell Cycle; Cell Division; Cell Line; Hypoxia; Mice; Misonidazole; Mitosis; Nitroimidazoles; Osteosarcoma; Oxygen; Sarcoma, Experimental; Time Factors | 1979 |
Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
Topics: Adenocarcinoma; Animals; Bone Neoplasms; Cell Hypoxia; Cells, Cultured; Contrast Media; Cricetinae; Cricetulus; Dogs; Fibroblasts; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Osteosarcoma; Radiation Tolerance; Radionuclide Imaging; Sarcoma, Experimental | 1989 |